Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CYTOO Sponsors the Motility Subgroup at the Biophysical Society Meeting

Published: Monday, January 28, 2013
Last Updated: Monday, January 28, 2013
Bookmark and Share
CYTOO will attend the Biophysical Society (BPS) 57th Annual Meeting in Philadelphia, Pennsylvania, USA to present its innovative Cell Culture Platform, based on adhesive micropatterns.

After the recent launch of the CYTOOplates Motility, specifically designed to study cell migration for screening applications in both oncology and drug discovery, the company has the great pleasure to sponsor the Motility subgroup.

The Biophysical Society’s subgroups allow members to meet and interact within more focusedCYTOOplates-Motility.gif areas in smaller groups. Subgroups hold scientific symposia and business meetings each year on Saturday preceding the start of the Annual Meeting. The mission of the Motility Subgroup is to understand the basic mechanisms that underlie motility and contractility of biological systems.

CYTOO is delighted to have the opportunity to present the Motility products and their unique characteristics to the subgroup members. To celebrate the first anniversary of the World Cell Race1, CYTOO launched in December the CYTOOplates Motility, the microplate version of the CYTOOchips Motility, a perfect tool for studying cell migration, showing characteristics closer to those found in vivo2.

CYTOO’s Motility products feature adhesive tracks of 4 different widths from 2.5 to 20 μm allowing a wide range of applications including single vs collective cell migration, cell pairing, and in other application areas, such as directional neurite outgrowth assays.

Attendees are invited to visit BPS booth #650 to discover the Motility products, and to discuss their 2D+ application with Alexandra Fuchs, PhD, COO, and Yoran Margaron, PhD, Research Scientist.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Olivier Pasquier Joins CYTOO as Chief Commercial Officer
Olivier Pasquier first graduated from the French University Nice-Sophia Antipolis in molecular biology. He then completed his background with a marketing MBA from ESCP Europe.
Monday, March 18, 2013
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!